Response Evaluation and Survival Prediction Following PD‐1 Inhibitor in Patients With Advanced Hepatocellular Carcinoma: Comparison of the RECIST 1.1, iRECIST, and mRECIST Criteria

Overview of attention for article published in Frontiers in oncology, December 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

policy: 1 policy source

twitter: 1 X user

Readers on

mendeley: 11 Mendeley

Summary Policy documents X

So far, Altmetric has seen 1 X post from an account with 6,555 followers.

New research: Response Evaluation and Survival Prediction Following PD‐1 Inhibitor in Patients With Advanced Hepatocellular Carcinoma: Comparison of the RECIST 1.1, iRECIST, and mRECIST Criteria: Background Precise evaluation of the efficacy of… https://t.

09 Dec 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.